Michael Charles Cope

Broker Network Holdings Ltd. operates a network of insurance brokers. It offers business support services such as marketing, human resources, legal, and information technology. The company was founded on February 16, 1994 and is headquartered in Knaresborough, the United Kingdom.

The Risk Factor Ltd. provides risk advisory services to the public and corporate sector. It specializes in delivering transparency of the insurance market through qualified risk practitioners working in-house. The company was founded by Mark Webb in April 1994 and is headquartered in Harrogate, the United Kingdom.

NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom.

Telegenic Ltd. provides broadcasting services. It operates mobile production units. The firm handles camera and VTRS, and T4 and T5 formidable standalone production centers. The company was founded by David Anthony Barber and Michael David Burnett Spencer in 1980 and is headquartered in High Wycombe, the United Kingdom.

Telegenic Holdings Ltd. provides television broadcasting services. The private company is based in High Wycombe, UK. The British company was founded in 2004.